Original language | English |
---|---|
Pages (from-to) | e186-e189 |
Journal | Haematologica |
Volume | 105 |
Issue number | 4 |
DOIs | |
Publication status | Published - 2020 |
Keywords
- HLA DPB1 antigen
- HLA DQB1 antigen
- adult
- aged
- clinical outcome
- female
- gene expression
- genotype
- graft survival
- graft versus host reaction
- hematopoietic stem cell transplantation
- HLA matching
- human
- incidence
- Letter
- major clinical study
- male
- prediction
- relapse
- single nucleotide polymorphism
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Comparative evaluation of biological HLA-DPB1 mismatch models for survival and graft versus host disease prediction after unrelated donor hematopoietic cell transplantation. / Lorentino, F.; Sacchi, N.; Oldani, E.; Miotti, V.; Picardi, A.; Gallina, A.M.; Crivello, P.; Bernasconi, P.; Saccardi, R.; Farina, L.; Benedetti, F.; Cerno, M.; Grassi, A.; Bruno, B.; Patriarca, F.; Ciceri, F.; Fleischhauer, K.; Vago, L.; Bonifazi, F.
In: Haematologica, Vol. 105, No. 4, 2020, p. e186-e189.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Comparative evaluation of biological HLA-DPB1 mismatch models for survival and graft versus host disease prediction after unrelated donor hematopoietic cell transplantation
AU - Lorentino, F.
AU - Sacchi, N.
AU - Oldani, E.
AU - Miotti, V.
AU - Picardi, A.
AU - Gallina, A.M.
AU - Crivello, P.
AU - Bernasconi, P.
AU - Saccardi, R.
AU - Farina, L.
AU - Benedetti, F.
AU - Cerno, M.
AU - Grassi, A.
AU - Bruno, B.
AU - Patriarca, F.
AU - Ciceri, F.
AU - Fleischhauer, K.
AU - Vago, L.
AU - Bonifazi, F.
N1 - Cited By :2 Export Date: 11 March 2021 CODEN: HAEMA Correspondence Address: Fleischhauer, K.; Institute for Experimental Cellular Therapy, Hufelandstraße 55, Germany; email: katharina.fleischhauer@uk-essen.de Funding details: DJCLS R 15-02 Funding details: RF-2011-02351998 Funding details: Conquer Cancer Foundation, CCF Funding details: Associazione Italiana per la Ricerca sul Cancro, AIRC, 14162 Funding details: José Carreras Leukämie-Stiftung Funding text 1: The authors would like to thank all investigators and data managers for their dedicated patient care. This work was supported by the Italian Ministry of Health (RF-2011-02351998 to F.C. and L.V., RF-2011-02348034 to L.V., N.S. and A.R., and TRANSCAN HLALOSS to L.V. and K.F.), by the Associazione Italiana per la Ricerca sul Cancro (Start-Up Grant #14162 to L.V.), by the ASCO Conquer Cancer Foundation (2014 Young Investigator Award to L.V.), the Deutsche Jos? Carreras Leuk?mie Stiftung (grants DJCLS R 15-02 and DJCLS 01 R/2017 to K.F.), the Josef Senker Stiftung to K.F., and by the DKMS Mechtild Harf Foundation (DKMS Mechtild Harf Research Grant 2015 to L.V. and DKMS Mechtild Harf Research Grant 2018 to P.C.). Funding text 2: care. This work was supported by the Italian Ministry of Health (RF-2011-02351998 to F.C. and Funding text 3: Conquer Cancer Foundation (2014 Young Investigator Award to L.V.), the Deutsche José Carreras Funding text 4: Stiftung to K.F., and by the DKMS Mechtild Harf Foundation (DKMS Mechtild Harf Research Grant
PY - 2020
Y1 - 2020
KW - HLA DPB1 antigen
KW - HLA DQB1 antigen
KW - adult
KW - aged
KW - clinical outcome
KW - female
KW - gene expression
KW - genotype
KW - graft survival
KW - graft versus host reaction
KW - hematopoietic stem cell transplantation
KW - HLA matching
KW - human
KW - incidence
KW - Letter
KW - major clinical study
KW - male
KW - prediction
KW - relapse
KW - single nucleotide polymorphism
U2 - 10.3324/haematol.2019.225177
DO - 10.3324/haematol.2019.225177
M3 - Article
VL - 105
SP - e186-e189
JO - Haematologica
JF - Haematologica
SN - 0390-6078
IS - 4
ER -